These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 24974260)
1. Hospitalist perspective on the treatment of skin and soft tissue infections. Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM Mayo Clin Proc; 2014 Oct; 89(10):1436-51. PubMed ID: 24974260 [TBL] [Abstract][Full Text] [Related]
2. Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment. Cardona AF; Wilson SE Clin Infect Dis; 2015 Sep; 61 Suppl 2():S69-78. PubMed ID: 26316560 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department. Walraven CJ; Lingenfelter E; Rollo J; Madsen T; Alexander DP J Emerg Med; 2012 Apr; 42(4):392-9. PubMed ID: 21524884 [TBL] [Abstract][Full Text] [Related]
4. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Lawrence KR; Golik MV; Davidson L Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720 [TBL] [Abstract][Full Text] [Related]
6. Treatment of infections due to resistant Staphylococcus aureus. Anstead GM; Cadena J; Javeri H Methods Mol Biol; 2014; 1085():259-309. PubMed ID: 24085702 [TBL] [Abstract][Full Text] [Related]
7. A practical guide to the treatment of complicated skin and soft tissue infections. Fung HB; Chang JY; Kuczynski S Drugs; 2003; 63(14):1459-80. PubMed ID: 12834364 [TBL] [Abstract][Full Text] [Related]
8. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525 [TBL] [Abstract][Full Text] [Related]
9. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE; Wells EM Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [TBL] [Abstract][Full Text] [Related]
10. Treatment options for uncomplicated community-acquired skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: oral antimicrobial agents. Zervos M Surg Infect (Larchmt); 2008; 9 Suppl 1():s29-34. PubMed ID: 18844472 [TBL] [Abstract][Full Text] [Related]
12. Emergency management of pediatric skin and soft tissue infections in the community-associated methicillin-resistant Staphylococcus aureus era. Mistry RD; Weisz K; Scott HF; Alpern ER Acad Emerg Med; 2010 Feb; 17(2):187-93. PubMed ID: 20370748 [TBL] [Abstract][Full Text] [Related]
13. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci. Napolitano LM Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494 [TBL] [Abstract][Full Text] [Related]
14. Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines. Moran GJ; Abrahamian FM; Lovecchio F; Talan DA J Emerg Med; 2013 Jun; 44(6):e397-412. PubMed ID: 23466022 [TBL] [Abstract][Full Text] [Related]
15. Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer? Tsoulas C; Nathwani D Int J Antimicrob Agents; 2015 Jul; 46(1):1-7. PubMed ID: 25982913 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China. Wu D; Wang Q; Yang Y; Geng W; Wang Q; Yu S; Yao K; Yuan L; Shen X Diagn Microbiol Infect Dis; 2010 May; 67(1):1-8. PubMed ID: 20227225 [TBL] [Abstract][Full Text] [Related]
17. Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria. Stevens DL J Infect; 2009 Sep; 59 Suppl 1():S32-9. PubMed ID: 19766887 [TBL] [Abstract][Full Text] [Related]
18. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Bassetti M; Baguneid M; Bouza E; Dryden M; Nathwani D; Wilcox M Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():3-18. PubMed ID: 24580738 [TBL] [Abstract][Full Text] [Related]
19. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus. Ray GT; Suaya JA; Baxter R Diagn Microbiol Infect Dis; 2013 May; 76(1):24-30. PubMed ID: 23537783 [TBL] [Abstract][Full Text] [Related]
20. Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections. Cunha BA Int J Antimicrob Agents; 2013 Dec; 42(6):497-9. PubMed ID: 24126085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]